Acute renal failure in different malignant tumors

Current Medicinal Chemistry

Volumn 23, Issue 19, 2016, Pages 2041-2046

  Radojevic Škodric, Sanja ^a   Bogdanović, Ljiljana ^a   Jovanović, Milena ^b   Baralic, Ivana ^c   Džamić, Zoran ^b   Gordon, Ron ^d   Ognjanovic, Simona ^e   Basta Jovanović, Gordana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e MEDTRONIC INC   (United States)

Author keywords

Acute renal failure; Hepatocellular carcinoma (hcc); Lymphoma; Multiple myeloma; Tumor lysis syndrome

Indexed keywords

ACUTE KIDNEY FAILURE; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CRITICALLY ILL PATIENT; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LIVER CELL CARCINOMA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE MYELOMA; PATHOGENESIS; REVIEW; TREATMENT PLANNING; TUMOR LYSIS SYNDROME; ACUTE KIDNEY INJURY; BLOOD; COMPLICATION; LIVER TUMOR; NEOPLASM; PATHOLOGY;

IMMUNOGLOBULIN LIGHT CHAIN;

ACUTE KIDNEY INJURY; CARCINOMA, HEPATOCELLULAR; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; LIVER NEOPLASMS; LYMPHOMA; MULTIPLE MYELOMA; NEOPLASMS; TUMOR LYSIS SYNDROME;

EID: 84981263643     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867323666160407113245     Document Type: Review

References (58)

1. Lanore, J.J.; Brunet, F.; Pochard, F.; Bellivier, F.; Dhainaut, J.F.; Vaxelaire, J.F.; Giraud, T.; Dreyfus, F.; Dreyfuss, D.; Chiche, J.D. Hemodialysis for ARF in patients with hematologic malignancies. Crit. Care Med., 1991, 19, 346-351.
2. Benoit, D.D.; Depuydt, P.O.; Vandewoude, K.H.; Offner, F.C.; Boterberg, T.; De Cock, C.A.; Noens, L.A.; Janssens, A.M.; Decruyenaere, J.M. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol. Dial. Transplant., 2005, 20, 552-558.
3. Azoulay, E.; Recher, C.; Alberti, C.; Soufir, L.; Leleu, G.; Le Gall, J.R.; Fermand, J.P.; Schlemmer, B. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med., 1999, 25, 1395-1401.
4. Azoulay, E.; Moreau, D.; Alberti, C.; Leleu, G.; Adrie, C.; Barboteu, M.; Cottu, P.; Levy, V.; Le Gall, J.R.; Schlemmer, B. Predictors of shorter mmortality in critically ill patients with solid malignancies. Intensive Care Med., 2000, 26, 1817-1823.
5. Darmon, M.; Thiery, G.; Ciroldi, M.; de Miranda, S.; Galicier, L.; Raffoux, E.; Le Gall, J.R.; Schlemmer, B.; Azoulay, E. Intensive care inpatients with newly diagnosed malignancies and a need forcancer chemotherapy. Crit. Care Med., 2005, 33, 2488-2493.
6. Bagshaw, S.M.; Laupland, K.B.; Doig, C.J.; Mortis, G.; Fick, G.H.; Mucenski, M.; Godinez-Luna, T.; Svenson, L.W.; Rosenal, T. Prognosis forlong-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit. Care, 2005, 9, R700-R709.
7. Munker, R.; Hill, U.; Jehn, U.; Kolb, H.J.; Schalhorn, A. Renal complications in acute leukemias. Haematologica. 1998, 83, 416-421.
8. Azoulay, E.; Fieux, F.; Moreau, D.; Thiery, G.; Rousselot, P.; Parrot, A.; Le Gall, J.R.; Dombret, H.; Schlemmer , B. Acute monocytic leukemia presenting as acute respiratory failure. Am. J. Respir. Crit. Care Med., 2003, 167, 1329-1333.
9. Benoit, D.D.; Depuydt, P.O.; Vandewoude, K.H.; Offner, F.C.; Boterberg, T.; De Cock, C.A.; Noens, L.A.; Janssens, A.M.; Decruyenaere, J.M. Outcome of severely ill patients with haematological malignancieswho received intravenous chemotherapy in the intensive care unit. Intensive Care Med., 2006, 32, 93-99.
10. Jasek, A.M.; Day, H.J. Acute spontaneous tumor lysis syndrome. Am. J. Hematol., 1994, 47, 129-131.
11. Jeha, S. Tumor lysis syndrome. Semin. Hematol., 2001, 38(4 Suppl. 10), 4-8.
12. Kalemkerian, G.P.; Darwish, B.; Varterasian, M.L. Tumor lysis syndrome in small cell carcinoma and other solid tumors. Am. J. Med., 1997, 103, 363-367.
13. Huo, T.I.; Wu, J.C.; Huang, Y.H. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome. Aliment. Pharmacol. Ther., 2004, 19, 999-1007.
14. Park, J.; Chung, H.C.; Lee, J.S.; Lee, B.M.; Kim, D.M.; Hwang, J.C.; Jo, M.W.; Noh, M.; Shin, J.W. Acute kidney injury after transarterial chemoembolization for hepatocellular carcinoma: a retrospective analysis. Blood Purif., 2008, 26, 454-459.
15. Cho, A.; Lee, J.E.; Kwon, G.Y.; Huh, W.; Lee, H.M.; Kim, Y.G.; Kim, D.J.; Oh, H.Y.; Choi, H.Y. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy. Nephrol. Dial. Transplant., 2011, 26, 3496-3501.
16. Dmoszyńska, A.; Kraj, M.; Walter-Croneck, A. Zalecenia Polskiej Grupy Szpiczakowej dotyczace rozpoznania i leczenia szpiczaka plazmocytowego. Acta. Haematol. Pol., 2009, 753-782.
17. Kumar, S.K.; Rajkumar, S.V.; Dispenzieri, A.; Lacy, M.Q.; Hayman, S.R.; Buadi, F.K.; Zeldenrust, S.R.; Dingli, D.; Russell, S.J.; Lust, J.A.; Greipp, P.R.; Kyle, R.A.; Gertz, M.A.. Improved survival in multiple myeloma and the impact of novel therapies. Blood, 2008, 111, 2516-2520.
18. Kumar S.K.; Mikhael J.R.; Buadi F.K.; Dingli D.; Dispenzieri A.; Fonseca R.; Gertz M.A.; Greipp P.R.; Hayman, S.R.; Kyle, R.A.; Lacy, M.Q.; Lust, J.A.; Reeder, C.B.; Roy, V.; Russell, S.J.; Short, K.E.; Stewart, A.K.; Witzig, T.E.; Zeldenrust, S.R.; Dalton, R.J.; Rajkumar, S.V.; Bergsagel, P.L. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines. Mayo. Clin. Proc., 2009, 84, 1095-1110.
19. Albarracin, F.; Fonseca, R. Plasma cell leukemia. Blood Rev., 2011, 25, 107-112.
20. Mahindra, A.; Hideshima, T.; Anderson, K. Multiple myeloma: biology of the disease. Blood. Rev., 2010, 24(Suppl 1), S5-S11.
21. Sawyer, J. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma. Cancer Genetics, 2011, 204, 3-12.
22. Garand, R.; Avet-Loiseau, H.; Accard, F.; Moreau, P.; Harousseau, J.L.; Bataille, R. t(11;14) and t(4;14) translocations correlated with mature lymphoplasmocytoid and immature morphology, respectively, in multiple myeloma. Leukemia, 2003, 17, 2032-2045.
23. Klassen, R.B.; Allen, P.L.; Batuman, V.; Crenshaw, K.; Hammond, T.G. Light chains are a ligand for megalin. J. Appl. Physiol., 2005, 98, 257-263.
24. Dember, L.M. Light chains, casts, sheets and fibrils: monoclonal immunoglobulin diseases and immunotactoid/fibrillaryglomerulopathy. Clin. J. Am. Soc. Nephrol., 2006, 1, 1320-1321.
25. Li, M.; Hering-Smith, K.S.; Simon, E.E.; Batuman, V. Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol. Dial. Transplant., 2008, 3, 860-870.
26. Basnayake, K.; Ying, W.Z.; Wang, P.X.; Sanders, P.W. Immunoglobulin light chains activate tubular epithelial cells through redox signaling. J. Am. Soc. Nephrol., 2010, 21, 1165-1173
27. Start, D.A.; Silva, F.G.; Davis, L.D.; D'Agati, V.; Pirani, C.L. Myeloma cast nephropathy: immunohistochemical and lectin studies. Mod. Pathol., 1988, 1, 336-347.
28. Davenport, A.; Merlini, G. Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities. Nephrol. Dial. Transplant., 2012, 10, 3713-3718.
29. Herrera, G.A.; Joseph, L.; Gu, X.; Hough, A.; Barlogie, B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch. Pathol. Lab. Med., 2004, 128, 875-879.
30. Khamlichi, A.; Rocca, A.; Touchard, G.; Aucouturier, P.; Preud'Homme, J.L.; Cogné, M. Role of light chain variable region in myeloma with light chain deposition disease: evidence from an experimental model. Blood, 1995, 86, 3655-3659.
31. Hutchison, C.A. ; Batuman, V. ; Behrens, V.; Bridoux, F.; Sirac, C.; Dispenzieri, A.; Herrera, G.A.; Lachmann, H.; Sanders, P.W.; International Kidney and Monoclonal Gammopathy Research Group. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat. Rev. Nephrol., 2011, 8, 43-51.
32. Woodruff, R.; Sweet, B. Multiple myeloma with massive Bence Jones proteinuria and preservation of renal function. Aust. N. Z. J. Med., 1977, 7, 60-62.
33. Hutchinson, A.T.; Ramsland, P.A.; Jones, D.R.; Agostino, M.; Lund, M.E.; Jennings, C.V.; Bockhorni, V.; Yuriev, E.; Edmundson, A.B.; Raison, R.L. Free Ig light chains interact with sphingomyelin and are found on the surface of myeloma plasma cells in an aggregated form. J. Immunol., 2010, 185, 4179-4188.
34. Hutchinson, A.T.; Malik, A.; Berkahn, M.B.; Agostino, M.; To, J.; Tacchi, J.L.; Djordjevic, S.P.; Turnbull, L.; Whitchurch, C.B.; Edmundson, A.B.; Jones, D.R.; Raison, R.L.; Ramsland, P.A. Formation of assemblies on cell membranes by secreted proteins: molecular studies of free λ light chain aggregates found on the surface of myeloma cells. Biochem. J., 2013, 454, 479-489.
35. Ying, W.Z.; Sanders, P.W. Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein. Am. J. Pathol., 2001, 158, 1859-1866.
36. Huang, Z.Q.; Sanders, P.W. Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein. J. Clin. Invest., 1997, 99, 732-736.
37. Rocca, A.; Khamlichi, A.A.; Touchard, G.; Mougenot, B.; Ronco, P.; Denoroy, L.; Deret, S.; Preud'homme, J.L.; Aucouturier, P.; Cogné, M. Sequences of VκL subgroup light chains in Fanconi's syndrome: light chain V region gene usage restriction and peculiarities in myelomaassociated Fanconi's syndrome. J. Immunol., 1995, 155, 3245-3252.
38. Messiaen, T.; Deret, S.; Mougenot, B.; Bridoux, F.; Dequiedt, P.; Dion, J.J.; Makdassi, R.; Meeus, F.; Pourrat, J.; Touchard, G.; Vanhille, P.; Zaoui, P.; Aucouturier, P.; Ronco, P.M. Adult Fanconi syndrome secondary to light chain gammopathy: clinicopathologic heterogeneity and unusual features in 11 patients. Medicine, 2000, 79, 135-154.
39. Blancas-Mejia, L.M.; Tellez, L.A.; del Pozo-Yauner, L.; Becerril, B.; Sanchez-Ruiz, J.M.; Fernandez-Velasco, D.A. Thermodynamic and kinetic characterization of a germ line human λ6 light-chain protein: the relation between unfolding and fibrillogenesis. J. Mol. Biol., 2009, 386, 2009.
40. Waikar, S.S.; Bonventre, J.V. Creatinine kinetics and the definition of acute kidney injury. J. Am. Soc. Nephrol., 2009, 20, 672-679.
41. Levey, A.S.; Eckardt, K.U.; Tsukamoto, Y.; Levin, A.; Coresh, J.; Rossert, J.; De Zeeuw, D.; Hostetter, T.H.; Lameire, N.; Eknoyan, G. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int., 2005, 67, 2089-2100.
42. Dimopoulos, M.A.; Terpos, E.; Chanan-Khan, A.; Leung, N.; Ludwig, H.; Jagannath, S.; Niesvizky, R.; Giralt, S.; Fermand, J.P.; Bladé, J.; Comenzo, R.L.; Sezer, O.; Palumbo, A.; Harousseau, J.L.; Richardson, P.G.; Barlogie, B.; Anderson, K.C.; Sonneveld, P.; Tosi, P.; Cavo, M.; Rajkumar, S.V.; Durie, B.G.; San Miguel, J. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J. Clin. Oncol. , 2010, 28, 4976-4984.
43. Terpos, E.; Christoulas, D.; Kastritis, E.; Katodritou, E.; Pouli, A.; Michalis, E.; Papassotiriou, I.; Dimopoulos, M.A. Greek Myeloma Study Group. The chronic kidney disease epidemiology collaboration cystatin C, (CKDEPI- CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma, is it time to change from MDRD to CKDEPI- CysC equations? Eur. J. Haematol., 2013, 91, 347-355.
44. Herrera, G.A.; Sanders, P.W. Paraproteinemic renal diseases that involve the tubulo-interstitium. In: The Kidney in Plasma Cell Dyscrasias, G. A. Herrera, Ed., Contrib. Nephrol. vol. 153, pp. 105-115, Karger, Basel, Switzerland, 2007.
45. Lanore, J.J.; Brunet, F.; Pochard, F.; Bellivier, F.; Dhainaut, J.F.; Vaxelaire, J.F.; Giraud, T.; Dreyfus, F.; Dreyfuss, D.; Chiche, J.D. Hemodialysis for acute renal failure in patientswith hematologicmalignancies, Crit. Care. Med., 1991, 19, 346-351.
46. Benoit, D.D.; Hoste, E.A.; Depuydt, P.O.; Offner, F.C.; Lameire, N.H.; Vandewoude, K.H.; Dhondt, A.W.; Noens, L.A.; Decruyenaere, J.M. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol. Dial. Transplant., 2005, 20, 552-558.
47. Azoulay, E.; Recher, C.; Alberti, C.; Soufir, L.; Leleu, G. ; Le Gall, J.R. ; Fermand, J.P. ; Schlemmer, B. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med., 1999, 25, 1395-1401.
48. Azoulay, E.; Moreau, D.; Alberti, C.; Leleu, G.; Adrie, C.; Barboteu, M.; Cottu, P.; Levy, V.; Le Gall, J.R.; Schlemmer, B. Predictors of shor term mortality in critically ill patients with solid malignancies. Intensive Care Med., 2000, 26, 1817-1823.
49. Darmon, M.; Thiery, G.; Ciroldi, M.; de Miranda, S. ; Galicier, L. ; Raffoux, E. ; Le Gall, J.R. ; Schlemmer, B. ; Azoulay, E. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit. Care. Med., 2005, 33, 2488-2493.
50. Hande, K.R.; Garrow, G.C. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. Am. J. Med., 1993, 94, 133-139.
51. Kjellstrand, C.M.; Campbell, D.C.; von Hartitzsch, B.; Buselmeier, T.J. Hyperuricemic acute renal failure. Arch. Intern. Med., 1974, 133, 349-359.
52. Tsokos, G.C.; Balow, J.E.; Spiegel, R.J.; Magrath, I.T. Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine, 1981, 60, 218-229.
53. Veenstra, J.; Krediet, R.T.; Somers, R.; Arisz, L. Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management. Neth. J. Med., 1994, 45, 211-216.
54. Jasek, A.M.; Day, H.J. Acute spontaneous tumor lysis syndrome. Am. J. Hematol., 1994, 47, 129-131.
55. Khalil, M.A.; Latif, H.; Rehman, A.; Kashif, W.U.; Awan, S.; Khalil, Z.; Mushtaq, U.; Ahmad, M.; Khalil, M.A.; Ranga, Sami, M.; Tan, J. Acute kidney injury in lymphoma: a single centre experience. Int. J. Nephrol., 2014, 2014, 272961.
56. Lameire, H.; Flombaum, C.D.; Moreau, D.; Ronco, C. Acute renal failure in cancer patients, Ann. Med., 2005, 37, 13-25.
57. Soares, M.; Salluh, J.I.F.; Carvalho, M.S.; Darmon, M.; Rocco, J.R.; Spector, N. Prognosis of critically ill patients with cancer and acute renal dysfunction. J. Clin. Oncol., 2006, 24, 4003-4010.
58. Lahoti, A.; Kantarjian, H.; Salahudeen, A.K.; Ravandi, F.; Cortes, J.E.; Faderl, S.; O'Brien, S.; Wierda, W.; Mattiuzzi, G.N. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or highriskmyelodysplastic syndrome. Cancer, 2010, 116, 4063-4068.